FDA Drops Prescriber Training for ESAs in Chemo Patients FDA Drops Prescriber Training for ESAs in Chemo Patients

The agency concluded that clinicians have a better handle on prescribing the erythropoiesis-stimulating agents for chemotherapy-related anemia and understanding their risks.News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news